Mullen G - Search Results

1

HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models.

Gómez V, Galazi M, Weitsman G, Monypenny J, Al-Salemee F, Barber PR, Ng K, Beatson R, Szokol B, Orfi L, Mullen G, Vanhaesebroeck B, Chowdhury S, Leung HY, Ng T. Gómez V, et al. Among authors: mullen g. Mol Cancer Ther. 2022 Apr 1;21(4):667-676. doi: 10.1158/1535-7163.MCT-21-0320. Mol Cancer Ther. 2022. PMID: 35086953 Free PMC article.

2

A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments.

Fruhwirth GO, Diocou S, Blower PJ, Ng T, Mullen GE. Fruhwirth GO, et al. J Nucl Med. 2014 Apr;55(4):686-94. doi: 10.2967/jnumed.113.127480. Epub 2014 Mar 6. J Nucl Med. 2014. PMID: 24604910 Free PMC article.

3

⁶⁸Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling.

Young JD, Abbate V, Imberti C, Meszaros LK, Ma MT, Terry SYA, Hider RC, Mullen GE, Blower PJ. Young JD, et al. J Nucl Med. 2017 Aug;58(8):1270-1277. doi: 10.2967/jnumed.117.191882. Epub 2017 Apr 13. J Nucl Med. 2017. PMID: 28408532 Free PMC article.

4

[¹⁸F]tetrafluoroborate-PET/CT enables sensitive tumor and metastasis in vivo imaging in a sodium iodide symporter-expressing tumor model.

Diocou S, Volpe A, Jauregui-Osoro M, Boudjemeline M, Chuamsaamarkkee K, Man F, Blower PJ, Ng T, Mullen GED, Fruhwirth GO. Diocou S, et al. Among authors: mullen ged. Sci Rep. 2017 Apr 19;7(1):946. doi: 10.1038/s41598-017-01044-4. Sci Rep. 2017. PMID: 28424464 Free PMC article.

5

A 99mTc-labelled scFv antibody fragment that binds to prostate-specific membrane antigen.

Nawaz S, Mullen GED, Blower PJ, Ballinger JR. Nawaz S, et al. Nucl Med Commun. 2017 Aug;38(8):666-671. doi: 10.1097/MNM.0000000000000698. Nucl Med Commun. 2017. PMID: 28598898 Free PMC article.

6

A Phase II, Open-label study to assess safety and management change using ⁶⁸Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.

Afaq A, Payne H, Davda R, Hines J, Cook GJR, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J. Afaq A, et al. Among authors: mullen g. J Nucl Med. 2021 Mar 19;62(12):1727-34. doi: 10.2967/jnumed.120.257527. Online ahead of print. J Nucl Med. 2021. PMID: 33741648 Free PMC article.

7

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Hofman MS, et al. J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986512 Free PMC article. Clinical Trial.

8

Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a ⁶⁸Ga-THP-scFv targeting the prostate-specific membrane antigen.

Nawaz S, Mullen GED, Sunassee K, Bordoloi J, Blower PJ, Ballinger JR. Nawaz S, et al. EJNMMI Res. 2017 Oct 25;7(1):86. doi: 10.1186/s13550-017-0336-6. EJNMMI Res. 2017. PMID: 29067565 Free PMC article.

9

Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?

Chia K, Paul RL, Weeks AJ, Naeem M, Mullen GED, Landau D, Blower PJ. Chia K, et al. Among authors: mullen ged. Nucl Med Biol. 2022 Jul-Aug;110-111:10-17. doi: 10.1016/j.nucmedbio.2022.04.004. Epub 2022 Apr 9. Nucl Med Biol. 2022. PMID: 35468342 Free article.

10

National Electrical Manufacturers Association NU-4 performance evaluation of the PET component of the NanoPET/CT preclinical PET/CT scanner.

Szanda I, Mackewn J, Patay G, Major P, Sunassee K, Mullen GE, Nemeth G, Haemisch Y, Blower PJ, Marsden PK. Szanda I, et al. Among authors: mullen ge. J Nucl Med. 2011 Nov;52(11):1741-7. doi: 10.2967/jnumed.111.088260. Epub 2011 Oct 3. J Nucl Med. 2011. PMID: 21969357 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page